tiprankstipranks
Exor NV (NL:EXO)
:EXO

Exor (EXO) AI Stock Analysis

Compare
17 Followers

Top Page

NL:EXO

Exor

(EXO)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - 5.2)
Rating:49Neutral
Price Target:
€69.00
▲(6.48% Upside)
Action:ReiteratedDate:10/10/25
Exor's overall stock score is primarily influenced by its mixed financial performance and bearish technical indicators. While the company shows strong profitability and a robust balance sheet, the significant revenue decline and cash flow issues are concerning. The technical analysis indicates a downtrend, and the low P/E ratio suggests potential undervaluation, but the modest dividend yield limits income potential.
Positive Factors
Low leverage / strong capital structure
Exor's very low leverage and high equity ratio provide durable financial flexibility: allows funding new investments, buybacks, or weathering downturns without distress. This structural strength supports long-term capital allocation and preserves optionality for strategic M&A or portfolio support.
Negative Factors
Severe revenue decline
A dramatic reported revenue drop signals underlying cash generation from operating assets is volatile or lumpy at the holding level. Sustained or repeated declines reduce distributable cash, limit reinvestment without disposals, and increase reliance on portfolio monetizations to fund strategy.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong capital structure
Exor's very low leverage and high equity ratio provide durable financial flexibility: allows funding new investments, buybacks, or weathering downturns without distress. This structural strength supports long-term capital allocation and preserves optionality for strategic M&A or portfolio support.
Read all positive factors

Exor (EXO) vs. iShares MSCI Netherlands ETF (EWN)

Exor Business Overview & Revenue Model

Company Description
Exor N.V., together with its subsidiaries, engages in the luxury goods, automotive, agricultural equipment, construction equipment, commercial vehicles, and professional football businesses. The company designs, engineers, produces, and sells luxu...
How the Company Makes Money
Exor generates revenue primarily through its investments in publicly traded and private companies. Its key revenue streams include dividends and capital gains from its equity holdings, particularly in automotive and media sectors. The company also...

Exor Earnings Call Summary

Earnings Call Date:Mar 23, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Sep 09, 2026
Earnings Call Sentiment Neutral
The call presented a balanced picture: strong internal actions and positive developments (Lingotto’s strong performance, meaningful buybacks, a fortified balance sheet, and improving execution at Philips) are offset by significant headwinds from major holdings (NAV decline driven by Ferrari, Stellantis and CNH), a very large discount to NAV, and ongoing operational challenges at key portfolio companies. Management emphasizes prudence, liquidity, and patient capital allocation entering a difficult 2026.
Positive Updates
Lingotto Reaches EUR 10 Billion AUM and Strong Performance
Lingotto reached roughly EUR 10 billion in assets under management and delivered an outstanding performance, with Lingotto rising ~40% in 2025, driven by its intersection/public strategy and selective third-party capital.
Negative Updates
NAV Per Share Decline in 2025
Net asset value (NAV) per share fell from EUR 178 at the start of the year to EUR 164.4 at year-end (a decline of ~7.6% or about EUR 13.6 per share), driven mainly by weak performance of several large holdings.
Read all updates
Q4-2025 Updates
Negative
Lingotto Reaches EUR 10 Billion AUM and Strong Performance
Lingotto reached roughly EUR 10 billion in assets under management and delivered an outstanding performance, with Lingotto rising ~40% in 2025, driven by its intersection/public strategy and selective third-party capital.
Read all positive updates
Company Guidance
Management guided a cautious, liquidity‑first approach for 2026 after a heavy 2025 of portfolio reset: NAV per share fell from EUR 178 to EUR 164.4 (a EUR 25/share hit mainly from Ferrari, Stellantis and CNH), Lingotto delivered +40% and reached ~EUR/USD 10 billion AUM, and Exor completed ~EUR 2.5 billion of buybacks over recent years (including EUR 1 billion in 2025) buying nearly 15% of shares at >50% discounts; balance‑sheet metrics cited included loan‑to‑value down to 6.9%, free cash flow/dividend ~6x, cash of EUR 1.4 billion, a doubled EUR 1.1 billion credit facility, EUR 600 million refinanced (maturing 2035), a $170 million private‑placement payment coming up, and expected ~EUR 3–4 billion of additional resources as announced transactions close (Iveco transactions valued at EUR 5.3 billion; divestments returning ~1.4x on cost). Priorities are to focus on larger holdings, simplify the portfolio, preserve capital and deploy capital with discipline (remaining interested in healthcare, luxury and technology and willing to take >5% positions where appropriate).

Exor Financial Statement Overview

Summary
Exor's financial performance is mixed. The income statement shows strong profitability margins but is overshadowed by a dramatic revenue decline. The balance sheet is robust with low leverage and high return on equity, reflecting financial stability. However, the cash flow statement raises concerns with a sharp decline in free cash flow growth and low operating cash flow coverage.
Income Statement
45
Neutral
Balance Sheet
60
Neutral
Cash Flow
40
Negative
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue-302.00M1.90B45.41B41.84B33.62B26.79B
Gross Profit-302.00M1.89B11.97B9.51B7.64B4.86B
EBITDA1.24B17.39B8.03B5.96B1.47B20.89M
Net Income-648.00M14.67B4.19B4.23B1.72B-30.00M
Balance Sheet
Total Assets40.00B42.46B94.78B83.70B91.11B172.94B
Cash, Cash Equivalents and Short-Term Investments1.53B153.00M8.66B13.51B7.70B35.79B
Total Debt3.54B4.09B40.22B48.05B28.95B70.02B
Total Liabilities3.64B4.25B61.65B54.03B66.74B135.28B
Stockholders Equity36.35B38.21B23.27B20.63B16.76B13.09B
Cash Flow
Free Cash Flow2.81B47.00M1.22B2.47B2.22B3.81B
Operating Cash Flow2.81B47.00M4.03B4.92B4.18B14.06B
Investing Cash Flow-92.00M-58.00M-8.73B-4.10B-29.59B-10.10B
Financing Cash Flow-1.98B-56.00M2.11B2.13B-2.19B10.63B

Exor Technical Analysis

Technical Analysis Sentiment
Negative
Last Price64.80
Price Trends
50DMA
70.11
Negative
100DMA
71.55
Negative
200DMA
77.84
Negative
Market Momentum
MACD
-1.96
Positive
RSI
37.27
Neutral
STOCH
45.31
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:EXO, the sentiment is Negative. The current price of 64.8 is below the 20-day moving average (MA) of 68.63, below the 50-day MA of 70.11, and below the 200-day MA of 77.84, indicating a bearish trend. The MACD of -1.96 indicates Positive momentum. The RSI at 37.27 is Neutral, neither overbought nor oversold. The STOCH value of 45.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NL:EXO.

Exor Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
€2.11B14.2925.42%2.44%11.67%36.03%
75
Outperform
€5.07B7.2415.92%4.27%-3.32%15.52%
74
Outperform
€2.41B11.4811.89%2.69%3.64%-22.13%
66
Neutral
€2.33B15.2314.59%2.85%-2.02%24.14%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
62
Neutral
€3.26B20.516.13%4.08%-4.31%-50.34%
49
Neutral
€20.70B-7.120.68%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NL:EXO
Exor
64.80
-25.08
-27.90%
NL:AALB
Aalberts Industries N.V.
30.20
-1.27
-4.02%
NL:ARCAD
Arcadis NV
27.44
-19.84
-41.96%
NL:BAMNB
Koninklijke Bam Groep NV
8.87
3.63
69.28%
NL:HEIJM
Heijmans N.V.
76.65
36.95
93.09%
NL:VPK
Royal Vopak NV
46.34
7.32
18.76%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 10, 2025